01 · Clinical
What was studied?
Population, design, comparator, endpoints, timeframe, adverse events, and funding.
Peptide research with receipts
Proof over hype.
We label what a claim actually is before deciding what weight it deserves: clinical evidence, regulatory status, seller claim, COA, independent test, or business assumption.
The method
Six lanes. No shortcuts.
Evidence can be strong in one lane and absent in another. A good trial does not verify a vial. A COA does not establish clinical benefit.
02 · Regulatory
What did an agency do?
Approval, investigation, advisory discussion, and compounding status are different events.
03 · Seller
What is being claimed?
Seller copy is a claim to examine, not independent verification.
04 · COA
What did the report test?
Identity, purity, content, sterility, and endotoxin are separate measurements.
05 · Independent test
What did one sample show?
A test can support its sample and batch context. It does not guarantee future units.
06 · Business
Who benefits?
Affiliate terms, sponsorships, discounts, and paid placement require plain disclosure.
Start here
Free proof utilities.
No account, vendor recommendation, or individualized health direction.
COA checklist
Check the lab, report ID, batch match, test date, and exact measurements.
Concentration calculator
Concentration arithmetic only. It never recommends an amount or tells anyone how much to draw.
PCAC explainer
What FDA’s July meeting can decide, what it cannot, and why discussion is not approval.
Proof Starter Pack
Evidence lanes, source hierarchy, a 15-point COA check, and a one-page claim audit.
Email capture is intentionally not active yet. No address will be collected until a provider, privacy language, retention rule, and working consent flow are selected and tested.